Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/mirnas-and-target-genes-in-breast-cancer-metastasis-introduction-role-LwiaJcdoSl
References (33)
-
Shaan Sarkar, H. Dubaybo, Shadan Ali, P. Goncalves, S. Kollepara, S. Sethi, P. Philip, Yiwei Li (2013)
Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.American journal of cancer research, 3 5
-
Tony Gutschner, S. Diederichs (2012)
The hallmarks of cancerRNA Biology, 9
-
R. Fernando, Mary Litzinger, Paola Trono, Duane Hamilton, J. Schlom, C. Palena (2010)
The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells.The Journal of clinical investigation, 120 2
-
D. Kong, Sanjeev Banerjee, Aamir Ahmad, Yiwei Li, Zhiwei Wang, S. Sethi, F. Sarkar (2010)
Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer CellsPLoS ONE, 5
-
S. Hsieh, M. Look, A. Sieuwerts, J. Foekens, K. Hunter (2009)
Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis studyBreast Cancer Research : BCR, 11
-
S. Sethi, Shadan Ali, D. Kong, P. Philip, F. Sarkar (2013)
Clinical implication of microRNAs in molecular pathology.Clinics in laboratory medicine, 33 4
-
C. DeSantis, Jiemin Ma, Leah Bryan, A. Jemal (2014)
Breast cancer statistics, 2013CA: A Cancer Journal for Clinicians, 64
-
J. Reis-Filho, L. Pusztai (2011)
Gene expression profiling in breast cancer: classification, prognostication, and predictionThe Lancet, 378
-
S. Sethi, F. Sarkar (2011)
Evolving Concept of Cancer Stem Cells: Role of Micro-RNAs and their Implications in Tumor AggressivenessJournal of carcinogenesis & mutagenesis, 2012
-
S. Sethi, D. Kong, S. Land, G. Dyson, W. Sakr, F. Sarkar (2013)
Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer.American journal of translational research, 5 2
-
A. Tsimberidou, N. Iskander, D. Hong, J. Wheler, G. Falchook, S. Fu, S. Piha-Paul, A. Naing, F. Janku, R. Luthra, Y. Ye, S. Wen, D. Berry, R. Kurzrock (2012)
Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center InitiativeClinical Cancer Research, 18
-
Ann Vernon, Suzanne Bakewell, L. Chodosh (2007)
Deciphering the molecular basis of breast cancer metastasis with mouse modelsReviews in Endocrine and Metabolic Disorders, 8
-
R. Baird, C. Caldas (2013)
Genetic heterogeneity in breast cancer: the road to personalized medicine?BMC Medicine, 11
-
C. Marchini, M. Montani, G. Konstantinidou, R. Orrù, S. Mannucci, G. Ramadori, Federico Gabrielli, A. Baruzzi, G. Berton, F. Merigo, Stefania Fin, M. Iezzi, B. Bisarò, A. Sbarbati, M. Zerani, M. Galiè, A. Amici (2010)
Mesenchymal/Stromal Gene Expression Signature Relates to Basal-Like Breast Cancers, Identifies Bone Metastasis and Predicts Resistance to TherapiesPLoS ONE, 5
-
N. Chau, M. Ashcroft (2003)
Akt2: a role in breast cancer metastasisBreast Cancer Research, 6
-
G. Hu, Yibin Kang, Xiao-Fan Wang (2009)
From breast to the brain: unraveling the puzzle of metastasis organotropism.Journal of molecular cell biology, 1 1
-
R. Weil, D. Palmieri, J. Bronder, A. Stark, P. Steeg (2005)
Breast cancer metastasis to the central nervous system.The American journal of pathology, 167 4
-
B. Bao, Shadan Ali, Aamir Ahmad, A. Azmi, Yiwei Li, Sanjeev Banerjee, D. Kong, S. Sethi, A. Aboukameel, S. Padhye, F. Sarkar (2012)
Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF TreatmentPLoS ONE, 7
-
B. Bao, A. Azmi, Shadan Ali, Aamir Ahmad, Yiwei Li, Sanjeev Banerjee, D. Kong, F. Sarkar (2012)
The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.Biochimica et biophysica acta, 1826 2
-
A. Qazi, Oksana Gruzdyn, A. Semaan, S. Seward, S. Chamala, V. Dhulipala, S. Sethi, R. Ali-Fehmi, P. Philip, D. Bouwman, D. Weaver, S. Gruber, R. Batchu (2012)
Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101.Surgery, 152 4
-
D. Nguyen, J. Massagué (2007)
Genetic determinants of cancer metastasisNature Reviews Genetics, 8
-
J. Krützfeldt, N. Rajewsky, Ravi Braich, K. Rajeev, T. Tuschl, M. Manoharan, M. Stoffel (2005)
Silencing of microRNAs in vivo with ‘antagomirs’Nature, 438
-
R. Punglia, M. Morrow, E. Winer, J. Harris (2007)
Local therapy and survival in breast cancer.The New England journal of medicine, 356 23
-
S. Sethi, Shadan Ali, P. Philip, F. Sarkar (2013)
Clinical Advances in Molecular Biomarkers for Cancer Diagnosis and TherapyInternational Journal of Molecular Sciences, 14
-
V. Guarneri, P. Conte (2009)
Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy.The oncologist, 14 7
-
D. Nguyen, Paula Bos, J. Massagué (2009)
Metastasis: from dissemination to organ-specific colonizationNature Reviews Cancer, 9
-
S. Sethi, Yiwei Li, F. Sarkar (2013)
Regulating miRNA by natural agents as a new strategy for cancer treatment.Current drug targets, 14 10
-
D. Kong, E. Heath, Wei Chen, M. Cher, I. Powell, L. Heilbrun, Yiwei Li, Shadan Ali, S. Sethi, O. Hassan, C. Hwang, N. Gupta, D. Chitale, W. Sakr, M. Menon, F. Sarkar (2012)
Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIMPLoS ONE, 7
-
Aamir Ahmad, A. Aboukameel, D. Kong, Zhiwei Wang, S. Sethi, Wei Chen, F. Sarkar, A. Raz (2011)
Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.Cancer research, 71 9
-
S. Sethi, F. Sarkar, Quratulain Ahmed, S. Bandyopadhyay, Z. Nahleh, A. Semaan, W. Sakr, A. Munkarah, R. Ali-Fehmi (2011)
Molecular markers of epithelial-to-mesenchymal transition are associated with tumor aggressiveness in breast carcinoma.Translational oncology, 4 4
-
Jiemin Ma, A. Jemal (2013)
Breast Cancer Statistics -
S. Sethi, J. Macoska, Wei Chen, F. Sarkar (2010)
Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis.American journal of translational research, 3 1
-
Shadan Ali, Husain Saleh, S. Sethi, F. Sarkar, Philip Philip (2012)
MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancerBritish Journal of Cancer, 107
- Publisher
- Springer International Publishing
- Copyright
- © Springer International Publishing Switzerland 2014
- ISBN
- 978-3-319-08161-8
- Pages
- 1 –6
- DOI
- 10.1007/978-3-319-08162-5_1
- Publisher site
- See Chapter on Publisher Site
Abstract
[Breast cancer is the most common cancer among women in the United States and the second leading cause of cancer deaths among women of all ages [1]. In 2013, there have been approximately 232,340 new cases of invasive breast cancer and 39,620 breast cancer deaths among US women [2]. One out of 8 women in the United States will develop breast cancer in her lifetime [2].]
Published: Sep 6, 2014
Keywords: Breast cancer; miRNA; Brain metastasis; Bone metastasis